Documents
Document Collection 287 total
| Document ID | Title | Source URL | Type | Auto Tags | Date | Actions | |
|---|---|---|---|---|---|---|---|
12e8385e...
|
Two-Year Real-World Study of LEQEMBI® in the Unite... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-07-30 | ||
3a6c3db4...
|
BIOGEN ALERT: Bragar Eagel & Squire, P.C. is Inves... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-08-13 | ||
13c85c2d...
|
Biogen Inc. Earnings Call Q3 2024 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2024-09-28 | ||
a8629666...
|
Ionis announces Biogen to advance salanersen into ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-25 | ||
4e3dd199...
|
Biogen and Stoke Therapeutics Announce Presentatio... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-08-25 | ||
254e2cb6...
|
Vertex Pharmaceuticals Incorporated Earnings Call ... | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
d4011414...
|
Biogen Announces $2 Billion Manufacturing Investme... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-07-21 | ||
2b51062f...
|
Samsung Bioepis to Commercialize BYOOVIZ® (ranibiz... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-29 | ||
d2f877ae...
|
Stoke Therapeutics and Biogen Announce Presentatio... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-07-10 | ||
8293ba41...
|
Biogen Inc. Earnings Call Q3 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
435a2a20...
|
Instem Taps ex-Novartis Head of Emerging Technolog... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2026-04-15 | ||
4fb0da8d...
|
FDA Approves LEQEMBI® IQLIK™ (lecanemab-irmb) Subc... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-08-29 | ||
e4eff664...
|
GSK plc Earnings Call Q3 2025 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2025-09-28 | ||
55c879d8...
|
Biogen Initiates Phase 3 Study of Felzartamab for ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-30 | ||
cb85f76c...
|
High Dose Regimen of Nusinersen Receives Positive ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-11-17 | ||
7d9d4252...
|
Biogen Inc. Earnings Call Q2 2024 | https://storage.googleapis.com/polarys-d... | transcript | No auto tags | 2024-06-28 | ||
9fa6bda2...
|
ZURZUVAE® (zuranolone) Receives Positive Opinion f... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-07-25 | ||
e1d39e77...
|
Biogen to Advance Investigational Spinal Muscular ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-06-25 | ||
90780365...
|
Health Canada Grants Authorization for “LEQEMBI®” ... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-10-26 | ||
c3d960d9...
|
“LEQEMBI®” (lecanemab) for the Treatment of Early... | https://storage.googleapis.com/polarys-d... | press_release | No auto tags | 2025-12-08 |
Showing 81 to 100 of 287 documents